Balchem (BCPC) Short Interest Ratio & Short Volume $165.24 -0.55 (-0.33%) Closing price 04:00 PM EasternExtended Trading$165.24 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Balchem Short Interest DataBalchem (BCPC) has a short interest of 416,500 shares, representing 1.29% of the float (the number of shares available for trading by the public). This marks a -6.61% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 139,202 shares to cover all short positions.Current Short Interest416,500 sharesPrevious Short Interest446,000 sharesChange Vs. Previous Month-6.61%Dollar Volume Sold Short$72.48 millionShort Interest Ratio3.0 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares32,533,000 sharesFloat Size32,330,000 sharesShort Percent of Float1.29%Today's Trading Volume174,389 sharesAverage Trading Volume139,202 sharesToday's Volume Vs. Average125% Short Selling Balchem? Sign up to receive the latest short interest report for Balchem and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCPC Short Interest Over TimeBCPC Days to Cover Over TimeBCPC Percentage of Float Shorted Over Time Remove Ads Balchem Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025416,500 shares $72.48 million -6.6%1.3%3 $174.03 2/15/2025446,000 shares $73.51 million +7.0%1.4%3.4 $164.82 1/31/2025416,700 shares $66.66 million -10.6%1.3%3.2 $159.96 1/15/2025465,900 shares $74.63 million -2.7%1.4%3.5 $160.18 12/31/2024478,800 shares $78.04 million -2.8%1.5%3.7 $162.99 12/15/2024492,400 shares $86.53 million +12.8%1.5%3.9 $175.73 11/30/2024436,600 shares $78.82 million -11.0%1.4%3.7 $180.52 11/15/2024490,300 shares $87.16 million +10.9%1.5%4.1 $177.77 10/31/2024442,200 shares $73.99 million -3.8%1.4%4 $167.33 10/15/2024459,800 shares $79.09 million +4.6%1.4%4.3 $172.01 Get the Latest News and Ratings for BCPC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter. 9/30/2024439,500 shares $77.35 million +0.8%1.4%3.8 $176.00 9/15/2024436,100 shares $74.93 million -17.2%1.4%3.6 $171.82 8/31/2024526,900 shares $93.28 million -0.2%1.6%4.6 $177.03 8/15/2024527,700 shares $88.51 million +2.2%1.6%4.6 $167.73 7/31/2024516,200 shares $91.60 million +28.9%1.6%4.4 $177.46 7/15/2024400,500 shares $67.26 million +5.4%1.2%3.8 $167.94 6/30/2024380,100 shares $58.52 million +13.9%1.2%4 $153.95 6/15/2024333,800 shares $50.30 million +3.5%1.0%3.7 $150.69 5/31/2024322,400 shares $49.52 million -19.2%1.0%3.5 $153.60 5/15/2024399,000 shares $62.39 million +23.7%1.2%4.3 $156.36 4/30/2024322,600 shares $45.61 million -4.4%1.0%3.2 $141.38 4/15/2024337,300 shares $49.50 million -5.7%1.1%3.4 $146.76 3/31/2024357,800 shares $55.44 million -0.1%1.1%3.5 $154.95 3/15/2024358,200 shares $56.02 million +15.2%1.1%3.3 $156.39 2/29/2024311,000 shares $48.89 million +23.9%1.0%2.6 $157.19 2/15/2024251,000 shares $36.74 million -8.7%0.8%2 $146.39 1/31/2024274,800 shares $38.52 million +6.0%0.9%2.5 $140.16 1/15/2024259,300 shares $36.52 million +6.0%0.8%2.4 $140.84 12/31/2023244,700 shares $36.40 million -11.6%0.8%2.4 $148.75 12/15/2023276,900 shares $38.84 million +7.8%0.9%2.7 $140.25 11/30/2023256,900 shares $32.04 million +0.0%0.8%2.8 $124.72 11/15/2023256,800 shares $31.94 million +19.9%0.8%3 $124.38 10/31/2023214,200 shares $24.90 million +1.9%0.7%2.5 $116.24 10/15/2023210,200 shares $26.28 million +2.3%0.7%2.4 $125.00 9/30/2023205,400 shares $25.48 million -7.7%0.6%2.3 $124.04 9/15/2023222,600 shares $30.00 million +5.9%0.7%2.6 $134.78 8/31/2023210,300 shares $29.55 million +4.2%0.7%2.4 $140.50 8/15/2023201,800 shares $27.96 million -29.9%0.6%2.2 $138.55 7/31/2023288,000 shares $38.81 million +3.6%0.9%3.1 $134.74 7/15/2023278,000 shares $36.35 million -3.4%0.9%3.1 $130.76This isn’t RSI, MACD, or anything you’ve seen before (Ad)No more getting faked out by false breakouts that immediately reverse. Just clean, precise entries when momentum is PROVEN to push prices in one direction. Even though I’ve kept this under wraps for months, it’s beginning to get clear to me that I might just be sitting on something that could change the narrative for a lot of traders. So, with that, I’ve recorded a short presentation that goes over how this is all possible and why now’s the best time to use this.See the presentation here. 6/30/2023287,800 shares $38.80 million -4.8%0.9%3.2 $134.81 6/15/2023302,300 shares $41.17 million -4.3%1.0%3.4 $136.20 5/31/2023316,000 shares $39.07 million +2.0%1.0%3.6 $123.63 5/15/2023309,900 shares $39.35 million -7.4%1.0%3.5 $126.97 4/30/2023334,700 shares $43.98 million +24.2%1.1%3.6 $131.40 4/15/2023269,600 shares $34.24 million +1.8%0.9%2.7 $127.00 3/31/2023264,900 shares $33.50 million -16.0%0.8%2.6 $126.48 3/15/2023315,300 shares $40.01 million +25.1%1.0%3.1 $126.88 2/28/2023252,000 shares $32.76 million -3.7%0.8%2.5 $130.00 2/15/2023261,600 shares $36.00 million +0.4%0.8%2.6 $137.62 1/31/2023260,700 shares $34.06 million -19.3%0.8%2.7 $130.63 1/15/2023323,200 shares $42.15 million +6.1%1.0%3.6 $130.41 12/30/2022304,500 shares $37.18 million +16.2%1.0%3.5 $122.11 12/15/2022262,000 shares $32.14 million -16.0%0.8%3 $122.69 11/30/2022312,000 shares $43.93 million -21.3%1.0%3.6 $140.80 11/15/2022396,400 shares $56.58 million -12.7%1.2%4.6 $142.73 10/31/2022454,200 shares $63.50 million -14.2%1.4%5.3 $139.80 10/15/2022529,200 shares $66.85 million +13.6%1.7%5.8 $126.32 9/30/2022466,000 shares $56.66 million +1.8%1.5%4.9 $121.58 9/15/2022457,700 shares $57.54 million -6.6%1.4%4.3 $125.71 8/31/2022490,100 shares $64.60 million +3.8%1.5%4.5 $131.82 8/15/2022472,300 shares $64.00 million -9.0%1.5%4.2 $135.50 7/31/2022519,200 shares $70.49 million +8.5%1.6%4.3 $135.76 7/15/2022478,500 shares $61.89 million +9.0%1.5%4.1 $129.34 6/30/2022439,000 shares $56.96 million -13.7%1.4%3.9 $129.74 6/15/2022508,500 shares $59.13 million +6.4%1.6%4.6 $116.29 5/31/2022478,000 shares $59.48 million +7.4%1.5%4.5 $124.43 5/15/2022444,900 shares $52.90 million +13.2%1.4%4 $118.91 4/30/2022393,200 shares $48.44 million +8.8%1.2%3.5 $123.20 4/15/2022361,300 shares $48.20 million -3.8%1.1%2.9 $133.42 3/31/2022375,600 shares $51.34 million -23.5%1.2%2.9 $136.70 3/15/2022490,900 shares $66.03 million +11.6%1.5%3.7 $134.50 2/28/2022439,800 shares $60.84 million +16.0%1.4%3.3 $138.34 2/15/2022379,000 shares $52.83 million -2.7%1.2%2.8 $139.38 1/31/2022389,400 shares $57.22 million +0.8%1.2%3 $146.94 1/15/2022386,300 shares $60.08 million -2.7%1.2%3.4 $155.52 12/31/2021397,000 shares $66.93 million -7.8%1.2%3.7 $168.60 12/15/2021430,700 shares $72.78 million +2.6%1.3%3.6 $168.97 11/30/2021419,800 shares $66.33 million +9.6%1.3%3.7 $158.00 11/15/2021382,900 shares $62.87 million -12.9%1.2%3.6 $164.19 10/29/2021439,400 shares $67.27 million -11.3%1.4%4.1 $153.09 10/15/2021495,100 shares $74.75 million -10.5%1.5%4.8 $150.97 9/30/2021553,400 shares $80.28 million +0.4%1.7%5.3 $145.07 9/15/2021551,200 shares $76.68 million +3.3%1.7%5.5 $139.12 8/31/2021533,400 shares $74.90 million +30.2%1.7%5.7 $140.42 8/13/2021409,800 shares $53.50 million +2.8%1.3%4.2 $130.56 7/30/2021398,500 shares $53.75 million -3.8%1.2%3.9 $134.89 7/15/2021414,100 shares $53.99 million +2.5%1.3%3.7 $130.39 6/30/2021403,900 shares $53.02 million -28.9%1.3%3.5 $131.26 6/15/2021567,700 shares $75.69 million +1.8%1.8%5 $133.32This isn’t RSI, MACD, or anything you’ve seen before (Ad)No more getting faked out by false breakouts that immediately reverse. Just clean, precise entries when momentum is PROVEN to push prices in one direction. Even though I’ve kept this under wraps for months, it’s beginning to get clear to me that I might just be sitting on something that could change the narrative for a lot of traders. So, with that, I’ve recorded a short presentation that goes over how this is all possible and why now’s the best time to use this.See the presentation here. 5/28/2021557,500 shares $73.03 million +4.5%1.7%4.7 $131.00 5/14/2021533,400 shares $71.05 million +2.5%1.7%4.6 $133.20 4/30/2021520,500 shares $64.86 million +7.5%1.6%4.5 $124.62 4/15/2021484,200 shares $58.97 million +2.9%1.5%4.3 $121.78 3/31/2021470,600 shares $59.57 million -10.3%1.5%3.8 $126.58 3/15/2021524,600 shares $68.57 million +0.7%1.6%4.1 $130.70 2/26/2021521,100 shares $62.57 million -9.9%1.6%4 $120.08 2/12/2021578,500 shares $68.92 million +2.4%1.8%4.3 $119.13 1/29/2021565,200 shares $61.51 million +18.6%1.8%3.7 $108.82 1/15/2021476,400 shares $58.93 million -7.3%1.5%3.1 $123.69 12/31/2020514,100 shares $58.86 million -7.1%1.6%3.9 $114.50 12/15/2020553,500 shares $60.88 million +15.9%1.7%4.3 $109.99 11/30/2020477,500 shares $50.27 million +14.8%1.5%3.8 $105.27 11/15/2020415,900 shares $44.17 million -14.9%1.3%3.4 $106.21 10/30/2020488,700 shares $48.99 million +5.4%1.5%4.9 $100.24 10/15/2020463,700 shares $47.93 million +1.7%1.4%4.4 $103.36 9/30/2020456,000 shares $44.52 million +6.8%1.4%4 $97.63 9/15/2020426,900 shares $41.03 million +5.6%1.3%3.5 $96.12 8/31/2020404,300 shares $39.50 million -8.7%1.3%3.2 $97.70 8/14/2020442,800 shares $44.48 million -14.3%1.4%3.2 $100.46 7/31/2020516,600 shares $51.79 million +19.2%1.6%3.3 $100.26 7/15/2020433,300 shares $41.47 million -12.4%1.4%2.6 $95.71 6/30/2020494,500 shares $46.65 million +0.3%1.5%2.9 $94.33 6/15/2020493,100 shares $44.85 million -8.7%1.5%2.8 $90.96 5/29/2020540,000 shares $54.15 million +8.1%1.7%3 $100.28 5/15/2020499,500 shares $43.11 million -2.1%1.6%2.8 $86.30 4/30/2020510,100 shares $45.52 million -6.3%1.6%3.3 $89.24 4/15/2020544,300 shares $53.58 million +14.5%1.7%4.1 $98.44 3/31/2020475,300 shares $43.59 million -17.5%1.5%3.7 $91.71 BCPC Short Interest - Frequently Asked Questions What is Balchem's current short interest? Short interest is the volume of Balchem shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 416,500 shares of BCPC short. 1.29% of Balchem's shares are currently sold short. Learn More on Balchem's current short interest. What is a good short interest ratio for Balchem? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCPC shares currently have a short interest ratio of 3.0. Learn More on Balchem's short interest ratio. Which institutional investors are shorting Balchem? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Balchem: Citadel Advisors LLC, Susquehanna International Group LLP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Balchem? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.29% of Balchem's floating shares are currently sold short. Is Balchem's short interest increasing or decreasing? Balchem saw a decline in short interest in February. As of February 28th, there was short interest totaling 416,500 shares, a decline of 6.6% from the previous total of 446,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Balchem's float size? Balchem currently has issued a total of 32,533,000 shares. Some of Balchem's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Balchem currently has a public float of 32,330,000 shares. How does Balchem's short interest compare to its competitors? 1.29% of Balchem's shares are currently sold short. Here is how the short interest of companies compare to Balchem: International Flavors & Fragrances Inc. (1.81%), RPM International Inc. (1.13%), Albemarle Co. (10.25%), Celanese Co. (7.99%), NewMarket Co. (1.36%), Sensient Technologies Co. (1.20%), H.B. Fuller (2.72%), Ashland Inc. (3.54%), Innospec Inc. (1.22%), Quaker Chemical Co. (11.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Balchem stock? Short selling BCPC is an investing strategy that aims to generate trading profit from Balchem as its price is falling. BCPC shares are trading down $141.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Balchem? A short squeeze for Balchem occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCPC, which in turn drives the price of the stock up even further. How often is Balchem's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCPC, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies IFF Short Squeeze RPM Short Squeeze ALB Short Squeeze CE Short Squeeze NEU Short Squeeze SXT Short Squeeze FUL Short Squeeze ASH Short Squeeze IOSP Short Squeeze KWR Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCPC) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Balchem Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Balchem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
